Answers are grounded in this paper and cite their sources.
The safety and efficacy of the S³ therapy concept relying on a short daily hemodialysis treatment using a bagged delivery system are in total agreement with daily HHD recommendations. Clinical performances are aligned to the metabolic needs of the vast majority of HHD patients. Currently ongoing studies at home will provide further evidence and value of this therapeutic approach.
No takes yet. Share an insight, caveat, or question.
Fessi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: